Morepen Laboratories informs about financial results

22 Jan 2018 Evaluate

Morepen Laboratories has informed that the Board of Directors of the Company, in their meeting held on Monday, 22nd January, 2018 (Timings: Meeting commenced at 8.30 a.m. and concluded at 9.22 a.m.), has considered and approved the Standalone Un-audited Financial Results of the Company for the Quarter and nine-months ended 31st December, 2017, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Morepen Laboratories Share Price

42.42 -1.03 (-2.37%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×